申请人:Janssen Pharmaceutica NV
公开号:US10323032B2
公开(公告)日:2019-06-18
The present invention is directed to a compound of Formula (I) or (Ia)
The invention also relates to pharmaceutical compositions comprising compounds of Formula (I) or (Ia). Methods of making and using the compounds of Formula (I) or (Ia) are also within the scope of the invention.
本发明涉及式 (I) 或 (Ia) 的化合物
本发明还涉及包含式(I)或(Ia)化合物的药物组合物。式(I)或(Ia)化合物的制造和使用方法也属于本发明的范围。